Abstract
Electrochemical analyses aided by density functional theory calculations were used to investigate the oxidative degradation of pyrazine antiviral drugs, 3-hydroxypyrazine-2-carboxamide (T-1105) and 6-fluoro-3-hydroxypyrazine-2-carboxamide (favipiravir, T-705), by electro-generated superoxide radical anion. T-1105 and T-705 are antiviral RNA nucleobase analogs that selectively inhibit the RNA-dependent RNA polymerase. They are expected as a drug candidate against various viral infections, including COVID-19. The pyrazine moiety was decomposed by superoxide through proton-coupled electron transfer (PCET). Our results show that its active form, pyrazine-ribofuranosyl-5'-triphosphate, is easily oxidized under inflamed organs by overproduced superoxide through the PCET mechanism in the immune system. This mechanistic study implies that the oxidative degradation of pyrazine derivatives will be prevented by controlling the PCET through simple modification of the pyrazine structure.
Supplementary materials
Title
supporting information
Description
Figure S1, CVs of O2/O2•− in the presence of acidic substrate; CV parameters; Figure S2, in situ Electrolytic UV–Vis (OTTLE) and ESR spectral system; Figure S3, conformers of T-1105 with dGs; Table S1-S4, comparison of dGs for the PCET in dimethyl sulfoxide, acetonitrile, water, and vacuum; Table S5-S6, charge distribution and natural population on the TS structures; Table S7-S8, Calculated geometries of TS.
Actions